COGT Stock Price
Cogent Biosciences, Inc.
COGT stock price is $28.15 (+0.21% on the day), giving Cogent Biosciences, Inc. a market cap of $4.87B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
COGT Stock Overview
- Price
- $28.15
- Previous close
- $28.09
- Open
- $28.09
- Market cap
- $4.87B
- P/E ratio
- -14.8
- 52-week range
- $13.78 - $43.73
- 1-year price target
- $55.82
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NGS
- MarketXLS Rank
- 32
About Cogent Biosciences, Inc.
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor in Phase 3 trial designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. The company also develops CGT4859, a reversible and selective fibroblast growth factor receptor 2 inhibitor in Phase 1 trial for patients with documented FGFR mutations, including advanced cholangiocarcinoma. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. Cogent Biosciences, Inc. is headquartered in Waltham, Massachusetts.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | COGT | $28.15 | +0.2% | 2.30M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cogent Biosciences, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW